1. Pollock G, Minuk GY. Diagnostic considerations for cholestatic liver disease. J Gastroenterol Hepatol. 2017 Jul;32(7):1303–9.
2. Fabris P, Tositti G, Mazzella G, Zanetti AR, Nicolin R, Pellizzer G, et al. Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study. Aliment Pharmacol Ther. 1999 Sep;13(9):1187–93.
3. Invernizzi P, Setchell KD, Crosignani A, Battezzati PM, Larghi A, O'Connell NC, et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology. 1999 Feb;29(2):320–7.
4. Daghman D, Rez MS, Soltany A, Alsaleh A. Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients. Oxf Med Case Reports. 2019 Aug;2019(8):omz080.
5. Noureddin M, Sander-Struckmeier S, Mato JM. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: a systematic review. World J Hepatol. 2020 Feb 27;12(2):46–63.